about
Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonistsPro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis.Signal peptide-binding drug as a selective inhibitor of co-translational protein translocationAnti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile.Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer.Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-gamma in autoimmune disease models.Specific CD4 down-modulating compounds with potent anti-HIV activity.CD4 down-modulating compounds with potent anti-HIV activity.Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs.Inhibitors of HIV infection via the cellular CD4 receptor.Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitorsProfile of resistance of human immunodeficiency virus to mannose-specific plant lectins.Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.Improving potencies and properties of CD4 down-modulating CADA analogs.Endothelial dysfunction in dengue virus pathology.A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA).Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies.Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4.Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.Chlorogenic Compounds from Coffee Beans Exert Activity against Respiratory Viruses.The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level.Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs).Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility.Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection.Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.Modest human immunodeficiency virus coreceptor function of CXCR3 is strongly enhanced by mimicking the CXCR4 ligand binding pocket in the CXCR3 receptor.Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes.Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues.CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry.CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor.Ribonuclease-neutralized pancreatic microsomal membranes from livestock for in vitro co-translational protein translocation.CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor.Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.Inhibitors of protein translocation across membranes of the secretory pathway: novel antimicrobial and anticancer agents.
P50
Q24802476-3EB087C3-A946-4F7A-8999-AE6E5625C953Q24812711-22341258-F5F6-4752-A402-2CD3DACC9223Q28542401-F3703B93-AD49-413D-9445-48D60601DBD6Q33223969-A20BAB6E-FA35-42FD-974A-CAFF3CDC78B4Q34042738-B1A38C4D-B756-4C23-8F5A-62AEE63EF66FQ34092638-B7EC5B99-6557-4C86-B51E-3A6949FF2CC6Q34295060-4C5E9E15-D549-409B-B7E8-5D47F0DD2713Q35213786-255914A0-6BA1-412A-B09F-03F8D9189845Q35794133-0A2606A6-1F69-4551-9EDE-58CD8AE7DA85Q36175730-13D79E29-C666-4513-80ED-BAE06D97887DQ36447157-2E94B535-C1C0-4A5D-A8FA-7096321CFF81Q36949688-ED16FAFF-4316-484B-8696-E890358A93DBQ37511474-B56E9B67-8866-4C1E-B658-ADC897824DAFQ37568901-D3C80137-1E13-45C5-B57E-F91806F0CCECQ37596456-6185888B-A939-4661-87E0-9F9E7522B682Q37999087-E8112315-9AED-4A4E-8287-4CF5F08B2BAFQ38272173-A1315A9C-8211-4DBB-9CA3-DEC42669B49DQ38725180-C9E8C71A-FD69-4F1E-B442-492ED5737947Q38786622-88CBC1CC-E2EB-498E-8F51-2134363004D0Q38838107-B450F1A7-14C8-41C9-A57E-227DECE43A7FQ39056166-D1D9B4D0-3BE6-4D2E-A2A5-0B78AB351883Q39223481-24202D41-CF92-4588-A4C1-E4F2125CA3A4Q39369243-09043395-6504-4D49-8826-29CDE0300D15Q39522649-BB0867CE-66BB-430B-A1BC-411C712803EDQ39556954-D543B7B3-0AEC-4420-B0CC-CE471570EC5AQ39830543-2F0E9EE7-5866-4EA4-AFAD-7520AA30DD8FQ39964308-B0C5F6E0-ADE2-400F-A4D5-612474383031Q40113231-F91D4A8C-F9D3-4942-96CE-78FEF4CAFEF6Q40179447-7F131DB3-4860-4057-B44B-4325F7D0B12DQ40204965-DAE48FA8-C6A9-46D6-A78F-11839B7A0D60Q40216885-97D8CBDE-9FA1-47CF-BDDA-899BEFA97AE5Q40316178-98494E00-8EFB-42B1-9D9B-AA34E8AE9B47Q40485195-C1A90973-11BB-4070-961D-2F68C5E1DC12Q40681253-193D8D14-7EE9-4B4A-BB7B-F7CC7BE0BD1BQ40688802-88B41302-6353-45A8-8F8E-0379E4C984DAQ41688735-420589FD-3D05-45E5-8854-C834DEAD7407Q43492997-E02C5BE0-8901-4ECD-8036-097268929A6AQ44253641-A61782D2-736B-4F83-BDEA-E2B8CA3946FAQ44495038-558170CC-68D1-4F37-ABBA-98EF3D996092Q47228430-4894E541-CFFC-457D-B0FC-BD927B39E631
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kurt Vermeire
@ast
Kurt Vermeire
@en
Kurt Vermeire
@es
Kurt Vermeire
@nl
Kurt Vermeire
@sl
type
label
Kurt Vermeire
@ast
Kurt Vermeire
@en
Kurt Vermeire
@es
Kurt Vermeire
@nl
Kurt Vermeire
@sl
prefLabel
Kurt Vermeire
@ast
Kurt Vermeire
@en
Kurt Vermeire
@es
Kurt Vermeire
@nl
Kurt Vermeire
@sl
P106
P31
P496
0000-0003-1123-1907